World Health Organization site
Skip Navigation Links

Please fill this short user satisfaction survey


Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: CTRI
Last refreshed on: 22 January 2024
Main ID:  CTRI/2023/12/060629
Date of registration: 21-12-2023
Prospective Registration: Yes
Primary sponsor: Sarada Krishna Homoeopathic Medical College
Public title: Homoeopathic management of Post Covid Syndrome
Scientific title: Assessment of IgG level in Persistent Post Covid Syndrome by administration of Calcarea carbonicum in 200th potency - NIL
Date of first enrolment: 01-01-2024
Target sample size: 60
Recruitment status: Not Yet Recruiting
URL:  http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=93779
Study type:  Interventional
Study design:  Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable  
Phase:  Phase 3/ Phase 4
Countries of recruitment
India
Contacts
Name: Dr M Murugan   
Address:  Sarada krishna Homoeopathic Medical College Kulasekharam Kanniyakumari Sarada krishna Homoeopathic Medical College Kulasekharam Kanniyakumari 629161 Kanniyakumari, TAMIL NADU India
Telephone: 9443343707
Email: drmmuruganhomoeo@gmail.com
Affiliation:  Department of Organon of medicine
Name: DrMMurugan   
Address:  Sarada krishna Homoeopathic Medical College Kulasekharam Kanniyakumari Sarada krishna Homoeopathic Medical College Kulasekharam Kanniyakumari 629161 Kanniyakumari, TAMIL NADU India
Telephone: 9443343707
Email: drmmuruganhomoeo@gmail.com
Affiliation:  Department of Organon of medicine
Key inclusion & exclusion criteria
Inclusion criteria: Symptomatic Covid patients

Cases associated with the systemic illness

Confirmed cases of RT-PCR

Exclusion criteria: Age below 18 years and above 65 years

Asymptomatic Covid patients

Patients with acute emergency conditions


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Intervention(s)
Control Intervention1: Calcarea carbonicum 200C: Dose 200C Frequency weekly once 1 dose Route of administration Oral route Duration for 6 months
Control Intervention2: Placebo: Placebo weekly once one dose Route via oral route Duration for 6 months
Primary Outcome(s)
Assessemnet of improvement by scoring chart of Delphi panel on monthly basisTimepoint: First assessment at 3rd month then last assessment at the end of 6th month
Secondary Outcome(s)
Assessment of IgG level before & after treatmentTimepoint: First assessment at the end of 3rd month & then next assessment at the end of 6th month
Secondary ID(s)
NIL
Source(s) of Monetary Support
Sarada Krishna Homoeopathic Medical College Kulasekharam Kanniyakumari
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 20/09/2023
Contact:
Institutional Ethics Committee SKHMC
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history Please fill this short user satisfaction survey